VOXEL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.8 PLN | -0.22% |
|
+2.65% | +18.07% |
| Mar. 11 | Amadeus IT Group Buys Voxel Media in EUR113 Million Deal | MT |
| 2023 | Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| Sales 2023 | 424M 106M | Sales 2024 * | 459M 114M | Capitalization | 975M 243M |
|---|---|---|---|---|---|
| Net income 2023 | 80M 19.93M | Net income 2024 * | 81M 20.18M | EV / Sales 2023 | 1.95 x |
| Net Debt 2023 * | 64.36M 16.03M | Net Debt 2024 * | 26.5M 6.6M | EV / Sales 2024 * | 2.18 x |
| P/E ratio 2023 * |
13.1
x | P/E ratio 2024 * |
12
x | Employees | 643 |
| Yield 2023 * |
3.83% | Yield 2024 * |
4.16% | Free-Float | 47.97% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.22% | ||
| 1 week | +2.65% | ||
| Current month | -0.22% | ||
| 1 month | +4.74% | ||
| 3 months | +12.90% | ||
| 6 months | +56.23% | ||
| Current year | +18.07% |
1 week
91.00
93.80
1 month
88.0095.80
Current year
74.8099.20
1 year
42.3099.20
3 years
32.5099.20
5 years
24.3099.20
10 years
8.8099.20
| Managers | Title | Age | Since |
|---|---|---|---|
Jaroslaw Furdal
CEO | Chief Executive Officer | 57 | 17-02-28 |
Alina Krupa
DFI | Director of Finance/CFO | - | 16-12-31 |
| Corporate Officer/Principal | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Katarzyna Galus
BRD | Director/Board Member | - | 21-06-28 |
| Director/Board Member | 36 | 16-06-22 | |
| Director/Board Member | 36 | 16-06-22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 92.8 | -0.22% | 39,165 |
| 24-04-30 | 93 | +0.87% | 27,035 |
| 24-04-29 | 92.2 | +1.99% | 12,397 |
| 24-04-26 | 90.4 | -1.09% | 1,324 |
Delayed Quote Warsaw S.E., May 02, 2024 at 11:55 am EDT
More quotes
Voxel SA is a Poland-based company active in the healthcare sector. It provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
92.8
PLN
Average target price
98
PLN
Spread / Average Target
+5.60%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +18.07% | 243M | |
| -18.58% | 8.3B | |
| +47.25% | 3.78B | |
| -8.58% | 2.47B | |
| -38.71% | 2.46B | |
| -10.06% | 2.31B | |
| -5.44% | 1.95B | |
| -17.79% | 1.59B | |
| -40.78% | 1.21B | |
| +6.69% | 1.1B |
- Stock Market
- Equities
- VOX Stock
